Resveratrol inhibits phenotype modulation by platelet derived growth factor-bb in rat aortic smooth muscle cells

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Lee, Mi Hee ^a   Kwon, Byeong Ju ^a,b   Seo, Hyok Jin ^a,b   Yoo, Kyeong Eun ^a,b   Kim, Min Sung ^a,b   Koo, Min Ah ^a,b   Park, Jong Chul ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; MODULATION; MUSCLE; PHOSPHORYLATION; PLATELETS; PROTEINS; RATS; SIGNAL TRANSDUCTION;

AKT ACTIVATION; DOSE-DEPENDENT; INTRACELLULAR SIGNALS; PLATELET DERIVED GROWTH FACTOR BB (PDGF BB); PROLIFERATION RATE; RAT AORTIC SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; VASCULAR SMOOTH MUSCLE CELLS;

RESVERATROL;

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 44; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; RESVERATROL; UNCLASSIFIED DRUG; ACTIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; STILBENE DERIVATIVE;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOFLUORESCENCE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL DEDIFFERENTIATION; CELL SHAPE; CYTOLOGY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; ACTINS; ANIMALS; AORTA; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-SIS; RATS; SIGNAL TRANSDUCTION; STILBENES;

EID: 84897496029     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/572430     Document Type: Article

References (35)

1. Davies M. G., Hagen P.-O., Pathobiology of intimal hyperplasia. British Journal of Surgery 1994 81 9 1254 1269 2-s2.0-0028122674 (Pubitemid 24275140)
2. Coats W. D., Faxon D. P., The role of the extracellular matrix in arterial remodelling. Seminars in Interventional Cardiology 1997 2 3 167 176 2-s2.0-0031216997
3. Schwartz S. M., Smooth muscle migration in atherosclerosis and restenosis. The Journal of Clinical Investigation 1997 99 12 2814 2817 2-s2.0-0030925749 (Pubitemid 27278654)
4. Kenji S., Ken'ichiro H., Wataru N., Molecular mechanism of phenotypic modulation of smooth muscle cells. Hormone Research 1998 50, supplement 2 15 24 2-s2.0-0031814463
5. Rzucidlo E. M., Martin K. A., Powell R. J., Lebanon N. H., Regulation of vascular smooth muscle cell differentiation. Journal of Vascular Surgery 2007 45 6 25 32 2-s2.0-34249307295 10.1016/j.jvs.2007.03.001 (Pubitemid 46818878)
6. Rozenblum G. T., Gimona M., Calponins: adaptable modular regulators of the actin cytoskeleton. International Journal of Biochemistry and Cell Biology 2008 40 10 1990 1995 2-s2.0-48949118319 10.1016/j.biocel.2007.07.010 (Pubitemid 352004269)
7. 2 for platelet-derived growth factor signal transduction. Science 1995 270 5234 296 299 2-s2.0-0028973482
8. Heldin C.-H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999 79 4 1283 1316 2-s2.0-0032875460 (Pubitemid 29473317)
9. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., Iwao H., Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 795 801 2-s2.0-0037625636 10.1161/01.ATV.0000066132. 32063.F2 (Pubitemid 36566168)
10. Sekulic A., Hudson C. C., Homme J. L., Yin P., Otterness D. M., Karnitz L. M., Abraham R. T., A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Research 2000 60 13 3504 3513 2-s2.0-0034234924 (Pubitemid 30482170)
11. Wullschleger S., Loewith R., Hall M. N., TOR signaling in growth and metabolism. Cell 2006 124 3 471 484 2-s2.0-32044465506 10.1016/j.cell.2006.01. 016 (Pubitemid 43199434)
12. Sadruddin S., Arora R., Resveratrol: biologic and therapeutic implications. Journal of the CardioMetabolic Syndrome 2009 4 2 102 106 2-s2.0-65349091486 10.1111/j.1559-4572.2008.00039.x
13. Wang X.-B., Huang J., Zou J.-G., Su E.-B., Shan Q.-J., Yang Z.-J., Cao K.-J., Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood. Clinical and Experimental Pharmacology and Physiology 2007 34 11 1109 1115 2-s2.0-34548696625 10.1111/j.1440-1681.2007. 04667.x (Pubitemid 47416343)
14. Brito P. M., Devillard R., Nègre-Salvayre A., Almeida L. M., Dinis T. C. P., Salvayre R., Augé N., Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 2009 205 1 126 134 2-s2.0-67349122064 10.1016/j.atherosclerosis.2008.11.011
15. Fremont L., Belguendouz L., Delpal S., Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sciences 1999 64 26 2511 2521 2-s2.0-0033591299 10.1016/S0024-3205(99)00209-X (Pubitemid 29268427)
16. Wang Z., Zou J., Cao K., Hsieh T.-C., Huang Y., Wu J. M., Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. International Journal of Molecular Medicine 2005 16 1 533 540 2-s2.0-33644688231
17. Sung H.-J., Eskin S. G., Sakurai Y., Yee A., Kataoka N., McIntire L. V., Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells. Annals of Biomedical Engineering 2005 33 11 1546 1554 2-s2.0-29144479934 10.1007/s10439-005-7545-2 (Pubitemid 41801641)
18. Li S., Sims S., Jiao Y., Chow L. H., Pickering J. G., Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circulation Research 1999 85 4 338 348 2-s2.0-0033588351 (Pubitemid 29398866)
19. Owens G. K., Regulation of differentiation of vascular smooth muscle cells. Physiological Reviews 1995 75 3 487 517 2-s2.0-0029048550
20. Owens G. K., Kumar M. S., Wamhoff B. R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological Reviews 2004 84 3 767 801 2-s2.0-3042588831 10.1152/physrev.00041.2003 (Pubitemid 38823766)
21. Rani P. U., Kesavan R., Ganugula R., Avaneesh T., Kumar P. U., Reddy G. B., Dixit M., Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats. Journal of Nutritional Biochemistry 2013 24 11 1830 1839 10.1016/j.jnutbio.2013.04.004
22. Griendling K. K., Ushio-Fukai M., Redox control of vascular smooth muscle proliferation. Journal of Laboratory and Clinical Medicine 1998 132 1 9 15 2-s2.0-0032126920 (Pubitemid 28329605)
23. Taniyama Y., Griendling K. K., Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003 42 6 1075 1081 2-s2.0-0348109425 10.1161/01.HYP.0000100443.09293.4F (Pubitemid 37549058)
24. Romano F., Chiarenza C., Palombi F., Filippini A., Padula F., Ziparo E., De Cesaris P., Platelet-derived growth factor-bb-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase. Journal of Cellular Physiology 2006 207 1 123 131 2-s2.0-33644882817 10.1002/jcp.20554
25. Reusch H. P., Zimmermann S., Schaefer M., Paul M., Moelling K., Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. Journal of Biological Chemistry 2001 276 36 33630 33637 2-s2.0-0035823542 10.1074/jbc.M105322200
26. Owens G. K., Wise G., Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors. Agents and Actions Supplements 1997 48 3 24 2-s2.0-0030918193 (Pubitemid 27230353)
27. Blank R. S., Owens G. K., Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. Journal of Cellular Physiology 1990 142 3 635 642 2-s2.0-0025250209
28. Gimona M., Kaverina I., Resch G. P., Vignal E., Burgstaller G., Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Molecular Biology of the Cell 2003 14 6 2482 2491 2-s2.0-0038308424 10.1091/mbc.E02-11-0743 (Pubitemid 36724336)
29. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A., Aoki J., Arai H., Sobue K., Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circulation Research 2001 89 3 251 258 2-s2.0-0035800886 (Pubitemid 34132683)
30. Corradetti M. N., Guan K.-L., Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 2006 25 48 6347 6360 2-s2.0-33750058023 10.1038/sj.onc.1209885 (Pubitemid 44582281)
31. Braun-Dullaeus R. C., Mann M. J., Seay U., Zhang L., Von der Leyen H. E., Morris R. E., Dzau V. J., Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 7 1152 1158 2-s2.0-0035408332 (Pubitemid 34215143)
32. Auge N., Garcia V., Maupas-Schwalm F., Levade T., Salvayre R., Negre-Salvayre A., Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 12 1990 1995 2-s2.0-0036920110 10.1161/01.ATV.0000043453.21629.3B (Pubitemid 36025204)
33. Stoclet J.-C., Chataigneau T., Ndiaye M., Oak M.-H., El Bedoui J., Chataigneau M., Schini-Kerth V. B., Vascular protection by dietary polyphenols. European Journal of Pharmacology 2004 500 1-3 299 313 2-s2.0-4644302860 10.1016/j.ejphar.2004.07.034 (Pubitemid 39304017)
34. El-Mowafy A. M., White R. E., Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Letters 1999 451 1 63 67 2-s2.0-0032911668 10.1016/S0014-5793(99)00541-4 (Pubitemid 29236173)
35. Ekshyyan V. P., Hebert V. Y., Khandelwal A., Dugas T. R., Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. Journal of Cardiovascular Pharmacology 2007 50 1 83 93 2-s2.0-34547674896 10.1097/FJC.0b013e318059ae80 (Pubitemid 47220451)